These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34400330)

  • 1. Silencing of ceramide synthase 2 in hepatocytes modulates plasma ceramide biomarkers predictive of cardiovascular death.
    Schmidt S; Gallego SF; Zelnik ID; Kovalchuk S; Albæk N; Sprenger RR; Øverup C; Pewzner-Jung Y; Futerman AH; Lindholm MW; Jensen ON; Ejsing CS
    Mol Ther; 2022 Apr; 30(4):1661-1674. PubMed ID: 34400330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for quantifying hepatic and intestinal ceramides on mice by UPLC-MS/MS.
    Ge K; Zheng D; Wang J; Jia W; Zhao A
    Anal Biochem; 2023 Jan; 661():114982. PubMed ID: 36375519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes.
    Mantovani A; Csermely A; Sani E; Beatrice G; Petracca G; Lunardi G; Bonapace S; Lippi G; Targher G
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide ratios are affected by cigarette smoke but not heat-not-burn or e-vapor aerosols across four independent mouse studies.
    Lavrynenko O; Titz B; Dijon S; Santos DD; Nury C; Schneider T; Guedj E; Szostak J; Kondylis A; Phillips B; Ekroos K; Martin F; Peitsch MC; Hoeng J; Ivanov NV
    Life Sci; 2020 Dec; 263():118753. PubMed ID: 33189821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.
    Laaksonen R; Ekroos K; Sysi-Aho M; Hilvo M; Vihervaara T; Kauhanen D; Suoniemi M; Hurme R; März W; Scharnagl H; Stojakovic T; Vlachopoulou E; Lokki ML; Nieminen MS; Klingenberg R; Matter CM; Hornemann T; Jüni P; Rodondi N; Räber L; Windecker S; Gencer B; Pedersen ER; Tell GS; Nygård O; Mach F; Sinisalo J; Lüscher TF
    Eur Heart J; 2016 Jul; 37(25):1967-76. PubMed ID: 27125947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI-HF trial.
    Targher G; Lunardi G; Mantovani A; Meessen J; Bonapace S; Temporelli PL; Nicolis E; Novelli D; Conti A; Tavazzi L; Maggioni AP; Latini R
    ESC Heart Fail; 2020 Dec; 7(6):3288-3297. PubMed ID: 32627354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating sphingolipids as biomarkers for the outcomes of acute ischemic stroke patients receiving endovascular treatment.
    Lee TH; Cheng CN; Lee CW; Kuo CH; Tang SC; Jeng JS
    J Formos Med Assoc; 2023 Jan; 122(1):19-28. PubMed ID: 36184387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia.
    Tkachev AI; Stekolshchikova EA; Morozova AY; Anikanov NA; Zorkina YA; Alekseyeva PN; Khobta EB; Andreyuk DS; Zozulya SA; Barkhatova AN; Klyushnik TP; Reznik AM; Kostyuk GP; Khaitovich PE
    Consort Psychiatr; 2021; 2(3):35-43. PubMed ID: 39044755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy.
    Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Canali G; Byrne CD; Gori S; Barbieri E; Targher G
    Metabolism; 2018 Aug; 85():305-312. PubMed ID: 29777715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes.
    Mantovani A; Altomari A; Lunardi G; Bonapace S; Lippi G; Bonnet F; Targher G
    Diabetes Metab; 2020 Sep; 46(4):326-330. PubMed ID: 31185304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Ceramide: A New Cardiometabolic Biomarker in Patients With Comorbid Acute Coronary Syndrome and Type 2 Diabetes Mellitus.
    Cao R; Fang Z; Li S; Xu M; Zhang J; Han D; Hu W; Yan L; Wang Y; Fan L; Cao F
    Front Physiol; 2020; 11():1104. PubMed ID: 33041846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential serum sphingolipid biomarkers for distinguishing Wilson disease.
    Tang S; Liang C; Yu H; Hou W; Hu Z; Chen X; Duan Z; Zheng S
    Clin Chim Acta; 2024 Jan; 553():117740. PubMed ID: 38145643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease.
    Mantovani A; Lunardi G; Bonapace S; Dugo C; Altomari A; Molon G; Conti A; Bovo C; Laaksonen R; Byrne CD; Bonnet F; Targher G
    Diabetes Metab; 2021 Feb; 47(1):101152. PubMed ID: 32283179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort.
    Havulinna AS; Sysi-Aho M; Hilvo M; Kauhanen D; Hurme R; Ekroos K; Salomaa V; Laaksonen R
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2424-2430. PubMed ID: 27765765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal obesity leads to long-term altered levels of plasma ceramides in the offspring as revealed by a longitudinal lipidomic study in children.
    León-Aguilar LF; Croyal M; Ferchaud-Roucher V; Huang F; Marchat LA; Barraza-Villarreal A; Romieu I; Ramakrishnan U; Krempf M; Ouguerram K; Mercado-Camargo R; Bolaños-Jiménez F
    Int J Obes (Lond); 2019 Jun; 43(6):1231-1243. PubMed ID: 30568270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of urinary sphingolipids using liquid chromatography-tandem mass spectrometry in diabetic nephropathy.
    Morita Y; Kurano M; Sakai E; Nishikawa T; Nishikawa M; Sawabe M; Aoki J; Yatomi Y
    J Diabetes Investig; 2020 Mar; 11(2):441-449. PubMed ID: 31580528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy.
    Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Gori S; Barbieri E; Verlato G; Laaksonen R; Byrne CD; Targher G
    Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2854-2861. PubMed ID: 30571175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Ceramides and Cardiovascular Events in Hypertensive Patients at High Cardiovascular Risk.
    Yin W; Li F; Tan X; Wang H; Jiang W; Wang X; Li S; Zhang Y; Han Q; Wang Y; Du J
    Am J Hypertens; 2021 Nov; 34(11):1209-1216. PubMed ID: 34232291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceramide stearic to palmitic acid ratio predicts incident diabetes.
    Hilvo M; Salonurmi T; Havulinna AS; Kauhanen D; Pedersen ER; Tell GS; Meyer K; Teeriniemi AM; Laatikainen T; Jousilahti P; Savolainen MJ; Nygård O; Salomaa V; Laaksonen R
    Diabetologia; 2018 Jun; 61(6):1424-1434. PubMed ID: 29546476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a high-throughput LC-MS/MS assay for routine measurement of molecular ceramides.
    Kauhanen D; Sysi-Aho M; Koistinen KM; Laaksonen R; Sinisalo J; Ekroos K
    Anal Bioanal Chem; 2016 May; 408(13):3475-83. PubMed ID: 26922344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.